Showing results (11-20 of 121) with videos related to
Sort By:
Pageof 13
Hematology/Oncology Clinics of North America|February 1, 1994
Bisphosphonates in breast cancer patients with skeletal metastasesC L ShapiroSeminars in Surgical Oncology|January 1, 1993
Relevance of quality of life assessment to the evaluation of combined-modality therapyC L ShapiroJournal of Internal Medicine|July 13, 2013
Circulating tumour cells: insights into tumour heterogeneityD F Hayes, C PaolettiPsycho-Oncology|September 6, 2001
Considerations in using tumor markers: what the psycho-oncologist needs to knowD L Fertig, D F HayesThe American Surgeon|May 1, 1976
Bilateral tube thoracostomy to preclude fatal tension pneumothorax in patients with acute respiratory insufficiencyD F Hayes, C E LucasBritish Journal of Cancer|December 1, 2005
The measurement and therapeutic implications of circulating tumour cells in breast cancerJ B Smerage, D F HayesArchives of Surgery (Chicago, Ill. : 1960)|August 1, 1980
Supradiaphragmatic right liver lobe and gallbladderC H Organ, D F HayesBreast Cancer Research and Treatment|March 5, 1999
Circulating tumor markers in breast cancer: accepted utilities and novel prospectsV Stearns, H Yamauchi, D F HayesJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2001
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancerH Yamauchi, V Stearns, D F HayesPageof 13